Herbalife Ltd's CFO John DeSimone participated in the Furey Research Partners Hidden Gems Conference on November 24, 2025. His engagement highlighted the company's leadership in health and nutrition, which may enhance investor confidence.
The webcast of the event is now available on Herbalife's Investor Relations website, expected to attract more investor attention and promote transparency. Herbalife has been providing science-backed nutrition products since 1980, operating in over 90 markets worldwide.
The company's focus on community support and one-on-one coaching through independent distributors encourages healthier lifestyles among customers. This strategy not only enhances customer satisfaction but may also drive sales growth and brand loyalty, contributing to the recent stock price increase.
Wall Street analysts forecast HLF stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLF is 14.60 USD with a low forecast of 8.00 USD and a high forecast of 20.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast HLF stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLF is 14.60 USD with a low forecast of 8.00 USD and a high forecast of 20.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
1 Hold
1 Sell
Moderate Buy
Current: 16.490
Low
8.00
Averages
14.60
High
20.00
Current: 16.490
Low
8.00
Averages
14.60
High
20.00
Mizuho
Neutral
maintain
$11 -> $13
2026-01-08
Reason
Mizuho
Price Target
$11 -> $13
AI Analysis
2026-01-08
maintain
Neutral
Reason
Mizuho raised the firm's price target on Herbalife to $13 from $11 and keeps a Neutral rating on the shares. The firm adjusted targets in the food producers space as part of its 2026 outlook. Healthy living growth should outperform in 2026, but concerns for competition have compressed valuations, the analyst tells investors in a research note. Mizuho believes weak fundamentals and elevated macro uncertainty "suggest limited prospects for a broad valuation recovery."
Maxim
Anthony Vendetti
Buy
initiated
$20
2026-01-06
Reason
Maxim
Anthony Vendetti
Price Target
$20
2026-01-06
initiated
Buy
Reason
Maxim analyst Anthony Vendetti initiated coverage of Herbalife with a Buy rating and $20 price target. A turnaround is underway, enabling Herbalife to solidify its status as a leading provider of health and wellness products, the analyst tells investors in a research note. Maxim believes the U.S. regulatory concerns are resolved, and the resulting changes, including closer alignment of distributor compensation with sales to end users, have established a more sustainable business model.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for HLF
Unlock Now
Cormark
Buy
to
Speculative Buy
downgrade
$24
2026-01-05
Reason
Cormark
Price Target
$24
2026-01-05
downgrade
Buy
to
Speculative Buy
Reason
Cormark downgraded High Liner Foods to Speculative Buy from Buy with a C$24 price target.
BofA
Underperform
maintain
$7 -> $8
2025-12-19
Reason
BofA
Price Target
$7 -> $8
2025-12-19
maintain
Underperform
Reason
BofA raised the firm's price target on Herbalife to $8 from $7 and keeps an Underperform rating on the shares. Entering 2026, the largest unresolved question for staples remains consumption growth and valuations remain dispersed across the group, but "there feels little to get them off the sidelines in '26 until fundamentals signal a greater turning of the tide," the analyst tells investors in a year-ahead note for the consumer staples group.
About HLF
Herbalife Ltd. is a global nutrition company. The Company sells weight management; targeted nutrition; energy, sports and fitness; and other nutrition products to and through a network of independent members. The Company has two geographical segments: Primary Reporting Segment (North America, Latin America, EMEA (Europe, Middle East, and Africa), and Asia Pacific regions) and China. Its products are classified into five categories. The Weight Management category includes meal replacements, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism-boosting teas. The Targeted Nutrition category features functional beverages and dietary supplements. The Energy, Sports, and Fitness category consists of products that support a healthy and active lifestyle. The Outer Nutrition segment offers facial skincare, body care, and hair care products. The Literature and Promotional Items include start-up kits, sales tools, and educational materials.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
